Psychopharmacology Bulletin
Overview
Psychopharmacology Bulletin is a peer-reviewed scientific journal that focuses on the latest research and advancements in the field of psychopharmacology. It publishes original articles, reviews, and case studies, providing valuable insights into the effects, mechanisms, and therapeutic applications of psychotropic drugs. This journal serves as a vital resource for researchers, clinicians, and pharmacologists interested in understanding the complex interplay between drugs and the human brain.
Details
Details
Abbr.
Psychopharmacol Bull
Start
1966
End
Continuing
Frequency
Quarterly
p-ISSN
0048-5764
e-ISSN
2472-2448
Country
United States
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 5503
66
SJR / Ranks: 9515
458
CiteScore / Ranks: 10891
1.90
Recent Articles
1.
Dixon M, Nixon R, ONeill J, Venters N
Psychopharmacol Bull
. 2025 Feb;
55(2):85-93.
PMID: 39935674
There is much uncertainty on continuing antipsychotics where a patient has an asymptomatic rise in creatine kinase. This case report describes a patient in his late 20s and early 30s...
2.
Mori-Kreiner A, Aggarwal A, Bordoloi M
Psychopharmacol Bull
. 2025 Feb;
55(2):94-99.
PMID: 39935673
Objective: Hallucinogen-persisting Perception Disorder (HPPD) is a rare condition characterized by the re-experiencing of one or more perceptual symptoms that an individual experienced while intoxicated with a hallucinogenic substance when...
3.
Baker J, Newman S
Psychopharmacol Bull
. 2025 Feb;
55(2):41-59.
PMID: 39935672
Schizophrenia is a serious mental illness that is a leading cause of disability worldwide. While antipsychotic agents are the most effective medications, up to one-third of patients experience treatment resistance,...
4.
Gama Marques J, Finsterer J
Psychopharmacol Bull
. 2025 Feb;
55(2):110-111.
PMID: 39935671
No abstract available.
5.
Ielmini M, Gallo D, Tanda M, Piantanida E, Callegari C, Caselli I
Psychopharmacol Bull
. 2025 Feb;
55(2):8-23.
PMID: 39935670
Recent mental health research has highlighted the critical role of inflammation in conditions like depression and bipolar disorder, examining correlations with markers such as calcium levels, thyroid function, and inflammatory...
6.
Malik A, Brown Z, Ryder A, Balayan V, Jameson L, Vu P, et al.
Psychopharmacol Bull
. 2025 Feb;
55(2):24-40.
PMID: 39935669
Fibromyalgia is a complex clinical entity characterized by a broad range of symptoms including chronic widespread musculoskeletal pain, profound fatigue, impaired cognition, and mood disturbances. Current understanding of disease pathogenesis...
7.
Birur S, Burk B, Fargason R, Alhassan A, Reddy A
Psychopharmacol Bull
. 2025 Feb;
55(2):60-74.
PMID: 39935668
Introduction: Although adolescent use of combustible cigarettes (CC) has decreased, the rise of nicotine electronic vaping products (EVPs) presents new public health concerns. Nicotine vaping devices, with appealing packaging and...
8.
Naguy A, Alablani D, Alamiri B
Psychopharmacol Bull
. 2025 Feb;
55(2):80-84.
PMID: 39935667
Fixed-dose combinations were, and still, quite in vogue in medical practice but for better or worse, did not gain a foothold in psychiatric prescriptions. Whilst briefing the merits and demerits...
9.
Mohammed M, Almarzogi A, Auf A
Psychopharmacol Bull
. 2025 Feb;
55(2):104-109.
PMID: 39935666
The relationship between antipsychotic medications and thyroid dysfunction has been highlighted in various studies and case reports, particularly concerning subclinical hypothyroidism. This report presents the case of a 31-year-old male...
10.
Peterson G, Byrne K, Dillon T, Naguy A, Turnier-Shea Y, Rybak M, et al.
Psychopharmacol Bull
. 2025 Feb;
55(2):100-103.
PMID: 39935665
Objective: A patient with major depressive disorder (MDD) was receiving transcranial magnetic stimulation (TMS). A little over halfway through the course the patient was bereaved and experienced normal sadness. Our...